Automated Stage Discrimination of Parkinson’s Disease
Background: Treatment plans for Parkinson’s disease (PD) are based on a disease stage scale, which is generally determined using a manual, observational procedure. Automated, sensor-based discrimination saves labor and costs in clinical settings and may offer augmented stage determination accuracy....
Main Authors: | Vered Aharonson, Nabeel Seedat, Simon Israeli-Korn, Sharon Hassin-Baer, Michiel Postema, Gilad Yahalom |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2020-09-01
|
Series: | BIO Integration |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/content/cscript/bioi/2020/00000001/00000002/art00001 |
Similar Items
-
The effects of sleep disturbance, race, sex, and age on Hoehn Yahr scores in Parkinson's disease patients: a cross-sectional study
by: Bayers, Christopher
Published: (2016) -
Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?
by: Vasfiye Burcu Albay, et al.
Published: (2020-09-01) -
Osteopontin is elevated in Parkinson’s disease and its absence leads to reduced neurodegeneration in the MPTP model
by: Walter Maetzler, et al.
Published: (2007-03-01) -
Skin Cancer May Delay Onset but Not Progression of Parkinson's Disease: A Nested Case-Control Study
by: Abhimanyu Mahajan, et al.
Published: (2020-05-01) -
Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study
by: Hiroshi Kataoka, et al.
Published: (2021-05-01)